Broad front against confidential reimbursement prices in…

Meeting of the Health Committee of the Bundestag /Maybaum Berlin – The federal government’s plans to allow confidential reimbursement prices met with widespread opposition in the Federal Health Committee today. Only the pharmaceutical associations spoke